Search Results - "Stass, S"

Refine Results
  1. 1

    Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer by Wang, J, Tian, X, Han, R, Zhang, X, Wang, X, Shen, H, Xue, L, Liu, Y, Yan, X, Shen, J, Mannoor, K, Deepak, J, Donahue, J M, Stass, S A, Xing, L, Jiang, F

    Published in Oncogene (27-02-2014)
    “…We have previously shown that miR-486-5p is one of the most downregulated micro RNAs in lung cancer. The objective of the study was to investigate the role of…”
    Get full text
    Journal Article
  2. 2

    Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach by LI, R, WANG, H, BEKELE, B. N, YIN, Z, CARAWAY, N. P, KATZ, R. L, STASS, S. A, JIANG, F

    Published in Oncogene (27-04-2006)
    “…Amplification and overexpression of putative oncogenes confer growth advantages for tumor development. We used a functional genomic approach that integrated…”
    Get full text
    Journal Article
  3. 3

    Targeted disruption of Aurora A causes abnormal mitotic spindle assembly, chromosome misalignment and embryonic lethality by Sasai, K, Parant, J M, Brandt, M E, Carter, J, Adams, H P, Stass, S A, Killary, A M, Katayama, H, Sen, S

    Published in Oncogene (03-07-2008)
    “…Aurora A (also known as STK15/BTAK in humans), a putative oncoprotein naturally overexpressed in many human cancers, is a member of the conserved Aurora…”
    Get full text
    Journal Article
  4. 4

    Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice by CHEN, Q.-R, KUMAR, D, STASS, S. A, MIXSON, A. J

    Published in Cancer research (Chicago, Ill.) (15-07-1999)
    “…Gene therapy transfer of angiostatin and endostatin represents an alternative method of delivering angiogenic polypeptide inhibitors. We examined whether…”
    Get full text
    Journal Article
  5. 5

    Co-polymer of histidine and lysine markedly enhances transfection efficiency of liposomes by CHEN, O.-R, ZHANG, L, STASS, S. A, MIXSON, A. T

    Published in Gene therapy (01-10-2000)
    “…Development of nonviral delivery systems is progressing toward a transfection efficiency sufficient to affect metabolic and neoplastic diseases in humans…”
    Get full text
    Journal Article
  6. 6

    The human MDM-2 oncogene is overexpressed in leukemias by BUESO-RAMOS, C. E, YUN YANG, DELEON, E, MCCOWN, P, STASS, S. A, ALBITAR, M

    Published in Blood (01-11-1993)
    “…The human homologue of the mouse double minute 2 (MDM-2) gene codes for a cellular protein that forms a complex with the mutant and wild-type p53 protein and…”
    Get full text
    Journal Article
  7. 7

    Isochromosome 7q: the primary cytogenetic abnormality in hepatosplenic γδ T cell lymphoma by ALONSOZANA, E. L. C, STAMBERG, J, ABRUZZO, L. V, KUMAR, D, JAFFE, E. S, MEDEIROS, L. J, FRANTZ, C, SCHIFFER, C. A, O'CONNELL, B. A, KERMAN, S, STASS, S. A

    Published in Leukemia (01-08-1997)
    “…Malignant lymphomas often have complex, nonrandom chromosomal abnormalities. Hepatosplenic γδ T cell lymphoma (γTCL) is an unusual post-thymic T cell lymphoma…”
    Get full text
    Journal Article
  8. 8

    Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity by Xu, M, Kumar, D, Srinivas, S, Detolla, L J, Yu, S F, Stass, S A, Mixson, A J

    Published in Human gene therapy (20-01-1997)
    “…Mutations of the p53 tumor suppressor gene are the most frequently observed genetic lesion in human cancer. Previously, we found that multiple intravenous…”
    Get more information
    Journal Article
  9. 9

    Branched co-polymers of histidine and lysine are efficient carriers of plasmids by Chen, Q R, Zhang, L, Stass, S A, Mixson, A J

    Published in Nucleic acids research (15-03-2001)
    “…We previously determined that a linear co-polymer of histidine and lysine (HK) in combination with liposomes enhanced the transfection efficiency of cationic…”
    Get full text
    Journal Article
  10. 10

    Detection of Minimal Residual Cells Carrying the t(14;18) by DNA Sequence Amplification by Lee, Ming-Sheng, Chang, Kun-Sang, Cabanillas, Fernando, Freireich, Emil J., Trujillo, Jose M., Stass, Sanford A.

    “…By means of the polymerase chain reaction (PCR) technique, DNA sequences were amplified that flank the crossover sites of a characteristic chromosomal…”
    Get full text
    Journal Article
  11. 11

    Change in karyotype between diagnosis and first relapse in acute myelogenous leukemia by Estey, E, Keating, M J, Pierce, S, Stass, S

    Published in Leukemia (01-06-1995)
    “…We compared karyotype at first relapse with presenting karyotype in 212 patients with AML seen at MD Anderson Cancer Center (Houston, TX, USA) between 1975 and…”
    Get more information
    Journal Article
  12. 12

    Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo by Xu, M, Kumar, D, Stass, S A, Mixson, A J

    Published in Molecular genetics and metabolism (01-02-1998)
    “…We recently reported that a p53 encoding plasmid (BAP-p53) complexed to liposomes administered intravenously markedly attenuates the growth of a malignant…”
    Get full text
    Journal Article
  13. 13

    Expression of AML1-ETO fusion transcripts and detection of minimal residual disease in t(8;21)-positive acute myeloid leukemia by Chang, K S, Fan, Y H, Stass, S A, Estey, E H, Wang, G, Trujillo, J M, Erickson, P, Drabkin, H

    Published in Oncogene (01-04-1993)
    “…The t(8;21) translocation breakpoint, which is observed in acute myeloid leukemia (AML), has recently been cloned and a fusion transcript identified. We have…”
    Get more information
    Journal Article
  14. 14

    HL-60 Cell Line Was Derived From a Patient With FAB-M2 and Not FAB-M3 by Dalton Jr, Willard T., Ahearn, Michael J., McCredie, Kenneth B., Freireich, Emil J, Stass, Sanford A., Trujillo, Jose M.

    Published in Blood (01-01-1988)
    “…The leukemia from which the human cell line HL-60 was derived was classified in 1976 as acute progranulocytic leukemia (APL), although it was recognized to…”
    Get full text
    Journal Article
  15. 15

    Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy by Berlyn, K.A, Ponniah, S, Stass, S.A, Malone, J.G, Hamlin-Green, G, Lim, J.K, Cottler-Fox, M, Tricot, G, Alexander, R.B, Mann, D.L, Malone, R.W

    Published in Journal of biotechnology (20-08-1999)
    “…Immunotherapy has been successfully used to treat some human malignancies, principally melanoma and renal cell carcinoma. Genetic-based cancer immunotherapies…”
    Get full text
    Journal Article Conference Proceeding
  16. 16

    Characterization of a fusion cDNA (RARA/myl) transcribed from the t(15;17) translocation breakpoint in acute promyelocytic leukemia by Chang, K S, Stass, S A, Chu, D T, Deaven, L L, Trujillo, J M, Freireich, E J

    Published in Molecular and Cellular Biology (01-02-1992)
    “…Article Usage Stats Services MCB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  17. 17

    Detection of Minimal Residual bcr/abl Transcripts by a Modified Polymerase Chain Reaction by Lee, Ming-Sheng, Chang, Kun-Sang, Freireich, Emil J., Kantarjian, Hagop M., Talpaz, Moshe, Trujillo, Jose M., Stass, Sanford A.

    Published in Blood (01-09-1988)
    “…The Philadelphia (Ph1) chromosome in chronic myelogenous leukemia (CML) involves reciprocal translocation of the bcr gene and the c-abl oncogene. The fused…”
    Get full text
    Journal Article
  18. 18

    Histologically discordant lymphomas with B-cell and T-cell components by ABRUZZO, L. V, GRIFFITH, L. M, NANDEDKAR, M, AGUILERA, N. S, TAUBENBERGER, J. K, RAFFELD, M, STASS, S. A, ABBONDANZO, S. L, JAFFE, E. S

    Published in American journal of clinical pathology (01-09-1997)
    “…We describe the clinical, histologic, immunophenotypic, and genotypic features of five cases of histologically discordant lymphomas with B-cell and T-cell…”
    Get full text
    Conference Proceeding Journal Article
  19. 19

    Oncogenes and tumor suppressor genes: therapeutic implications by Stass, S A, Mixson, J

    Published in Clinical cancer research (01-12-1997)
    “…Genetic instability is a hallmark of cancer. Alterations in DNA through mutations, deletions, and translocations affect genes that are fundamental to normal…”
    Get full text
    Journal Article
  20. 20

    Detection of Minimal Residual Disease by Polymerase Chain Reaction in Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Following Interferon Therapy by Lee, Ming-Sheng, Kantarjian, Hagop, Talpaz, Moshe, Freireich, Emil J., Deisseroth, Albert, Trujillo, Jose M., Stass, Sanford A.

    Published in Blood (15-04-1992)
    “…The significance of the polymerase chain reaction (PCR) in the detection of minimal residual disease in Philadelphia chromosome (Ph’)-positive chronic…”
    Get full text
    Journal Article